Does metoclopramide improve quality of endoscopy in acute upper gastrointestinal bleeding?.

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000745640

Enrollment

Registered

2005-11-16

Start date

2006-05-15

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

This study aims to investigate whether the administration of intravenous 10mg metoclopramide, 30-60minutes prior to endoscopy will improve the quality of endoscopic examination, will reduce the duration of endoscopic procedure and will decrease the need for repeat endoscopy

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Diagnosis

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Upper GI bleeding defined as either fresh and bright red or coffee ground haematemesis, Admission within 12 hours of initial clinical signs of bleeding and Written informed consent from patient.

Exclusion criteria

Previous allergy to metoclopramide, use of Nasogastric tube or gastric lavage, Prior gastrectomy, Pregnancy or lactation, Unable to give informed consent for any reason, Parkinsons disease and other contraindication to use of metoclopramide, Severe renal impairment and Advanced liver disease .

Outcome results